+
Site Tour

Search

Showing 1 - 10 of 532 results.

  • Connext

    Therapies Valvular Diseases Mitral Valve Disease Aortic Valve Disease Tricuspid Valvle Disease Paravalvular Leak
  • Amplatzer Piccolo™ Occluder

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure AMPLATZER PICCOLO™ OCCLUDER: FOR PDA CLOSURE IN THE SMALLEST PATIENTS INDUSTRY-LEADING
  • Amplatzer™ Duct Occluder

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure AMPLATZER™ DUCT OCCLUDER: FOR LARGE PDA CLOSURE
  • Amplatzer™ Duct Occluder II

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure AMPLATZER™ DUCT OCCLUDER II: VERSATILITY TO CONFORM TO A VARIETY OF PDAs
  • Patients who benefit

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure Constriction of the ductus arteriosus is a critical step in postnatal circulatory transi
  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neonatology regarding PDA closure
  • Overview

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion WATCH ON DEMAND: IMAGING WEBINARS 2025  LAAO SUMMIT 2025 LEARN MORE:
  • Launch Video

    WELCOME TO MY-CONNEXT.COM
  • Guidelines

    Asymptomatic patients Intervention is recommended in asymptomatic patients with severe aortic stenosis and systolic LV dysfunction (LVEF <50%) without another cause (class I, B). Interventi
  • Overview

    Two Types of Mitral Regurgitation 1-YEAR MORTALITY UP TO 57%* Mitral regurgitation, if left untreated, initiates a ca

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline